So excited to report that our Phase 2 study of a topical JAK inhibitor for lichen sclerosus was JUST published in the Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/42103188/
IF YOU WANT TO PARTICIPATE IN THE NEW PHASE 3 TRIAL OF A JAK INHIBITOR FOR LS AND LIVE NEAR NEW YORK CITY, WASHINGTON, DC OR TAMPA PLEASE EMAIL US AT RESEARCH.CVVD@GMAIL.COM
WE HAVE SEVERAL NEW TREATMENT STUDIES FOR BOTH LICHEN SCLEROSUS AND VULVODYNIA. GO TO [VULVODYNIA.COM/RESEARCH](http://VULVODYNIA.COM/RESEARCH) TO READ ABOUT THEM. email [research.cvvd@gmail.com](mailto:research.cvvd@gmail.com) if you want to participate: New York City, Washington, DC, Tampa (only, please don't ask about other locations, there aren't any).